The system for funding scientific research is broken.
This declaration came to my mind after I experienced three separate occurrences. The first was my application for a European research grant. At the end of the evaluation procedure, the reviewers wrote that my proposal was interesting, I had a good track record of publications, and the project had been well described. Nevertheless, they had... read
Help cancer and cardiovascular diseases research, and work with us to brin our brains back from foreign countries.
Please, give your 5x1000 to Human Health Foundation Onlus.
Tax Identification Code 02896450547
Sign up for the support of non-profit Social Organizations and support our Institute of Biosciences for Human Health of Terni.Together we can do a lot.
To better know us go to:... read
A year ago a group of researchers from various Italian universities and research centers decided to establish the Stem Cell Research Italy Association (www.stemcellitaly.org).
The SCR Italy has the main purpose of promoting scientific research in the field of stem cells through the study and dissemination of disciplines that have as their object the study of stem cells. Members of SCR Italy are... read
INTRODUCTION
Spitz naevus (SN) is an uncommon, benign melanocytic neoplasm that shares many clinical and histological features with melanoma (1). SN presents clinical ambiguity that makes the diagnosis and management of the patient difficult. There is no consensus concerning management of Spitz naevi (SNi) (2-4). Much more is still to be learnt about its evolution, modifications seen clinically... read
Introduction
The management of SCLC has been recently improved and survival rates are 15-25% at 2 years among patients with limited stage and 0-3% among those with extensive disease. The median overall survival with the combination chemotherapy is 14 to 16 months for patients with limited disease and 8 to 11 months for those with extensive disease. Most controlled clinical trials of SCLC define... read
